Taiwan has given emergency use authorization (EUA) to a COVID-19 vaccine developed by Taiwan-based Medigen Vaccine Biologics Corp. after a panel of experts felt its data on the vaccine's production of antibodies in Phase 2 trials met local standards.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan High Speed Rail plans new non-reserved seat rules in 2026
08/20/2025 09:51 PM - Politics
Proposal to extend HSR to Yilan passes environmental impact assessment
08/20/2025 09:19 PM - Business
Taiwan's export orders rise to new high in July spurred by AI demand
08/20/2025 08:52 PM - Business
Taiwan High Speed Rail shows next-generation bullet trains' livery, name
08/20/2025 07:01 PM - Politics
Ex-Interior Minister Hsu Kuo-yung named DPP secretary-general
08/20/2025 06:05 PM